_id

69104ee1ccc777a4e85d5366

Ticker

CING

Name

Cingulate Inc

Exchange

NASDAQ

Address

1901 West 47th Place, Kansas City, KS, United States, 66205

Country

USA

Sector

Healthcare

Industry

Biotechnology

Currency

USD

Website

https://www.cingulate.com

Description

Cingulate Inc., a biopharmaceutical company, develops pharmaceutical products using delivery platform technology for the treatment of attention deficit/hyperactivity disorder (ADHD) and anxiety in the United States. The company's lead product candidate is CTx-1301 (dexmethylphenidate), which is in Phase 3 clinical trials. It also develops CTx-2103 (buspirone) that is in a formulation stage for the treatment of anxiety and mental health disorders; and plans to initiate the clinical plan for CTx-1302 (dextroamphetamine) to treat ADHD in children, adolescents, and adults. Cingulate Inc. was founded in 2012 and is headquartered in Kansas City, Kansas.

Last Close

4.18

Volume

152595

Current Price

4.44

Change

6.220095693779921

Last Updated

2025-11-29T11:29:33.131Z

Image

data:image/webp;base64,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

Ipo Date

2021-12-08T00:00:00.000Z

Market Cap

25203872

Next Dividend Date

-

Dividend Frequency

-

Dividend Rate

-

Dividend Yield

0

Sentiment

0.929

Sentiment Sources

2

Rating

4.25

Target Price

27.1433

Strong Buy

1

Buy

3

Hold

0

Sell

0

Strong Sell

0

Current Quarter

2025-09-30

Revenue

0

Cost Of Revenue

106782

Gross Profit

-106782

Operating Expenses

5889053

Operating Income

-5995835

Interest Expense

573058000

Pretax Income

-7341062

Net Income

-7341062

Eps

-1.3516449201153482

Dividends Per Share

-

Shares Outstanding

6757070

Income Tax Expense

-

EBITDA

-7234278

Operating Margin

-

Total Other Income Expense Net

-1345227

Cash

6118710

Short Term Investments

-

Receivables

19041

Inventories

-

Total Current Assets

7433310

Property Plant Equipment

3085582

Total Assets

10518892

Payables

866245

Short Term Debt

3415888

Long Term Debt

-

Total Liabilities

7045206

Equity

3473686

Depreciation

106782

Change In Working Capital

1099643

Cash From Operations

-4244354

Capital Expenditures

4

Cash From Investing

-

Cash From Financing

1462881

Net Change In Cash

-2781473

PE

-

PB

6.942065183784602

ROE

-211.33349416153334

ROA

-69.78930860778873

FCF

-4244358

Fcf Percent

-

Piotroski FScore

1

Health Score

21

Deep Value Investing Score

2

Defensive Investing Score

5.5

Dividend Investing Score

1.5

Economic Moat Investing Score

2.8

Garp Investing Score

0.5

Growth Investing Score

0.5

Momentum Investing Score

2

Net Net Investing Score

1.5

Quality Investing Score

1

Value Investing Score

1.5

Quarters > 0 > quarter

2025-09-30

Quarters > 0 > income Statement > revenue

0

Quarters > 0 > income Statement > cost Of Revenue

106782

Quarters > 0 > income Statement > gross Profit

-106782

Quarters > 0 > income Statement > operating Expenses

5889053

Quarters > 0 > income Statement > operating Income

-5995835

Quarters > 0 > income Statement > interest Expense

573058000

Quarters > 0 > income Statement > pretax Income

-7341062

Quarters > 0 > income Statement > net Income

-7341062

Quarters > 0 > income Statement > eps

-1.3516449201153482

Quarters > 0 > income Statement > dividends Per Share

-

Quarters > 0 > income Statement > shares Outstanding

5431206

Quarters > 0 > income Statement > income Tax Expense

-

Quarters > 0 > income Statement > EBITDA

-7234278

Quarters > 0 > income Statement > operating Margin

-

Quarters > 0 > income Statement > total Other Income Expense Net

-1345227

Quarters > 0 > balance Sheet > cash

6118710

Quarters > 0 > balance Sheet > short Term Investments

-

Quarters > 0 > balance Sheet > receivables

19041

Quarters > 0 > balance Sheet > inventories

-

Quarters > 0 > balance Sheet > total Current Assets

7433310

Quarters > 0 > balance Sheet > property Plant Equipment

3085582

Quarters > 0 > balance Sheet > total Assets

10518892

Quarters > 0 > balance Sheet > payables

866245

Quarters > 0 > balance Sheet > short Term Debt

3415888

Quarters > 0 > balance Sheet > long Term Debt

-

Quarters > 0 > balance Sheet > total Liabilities

7045206

Quarters > 0 > balance Sheet > equity

3473686

Quarters > 0 > cash Flow > net Income

-7341062

Quarters > 0 > cash Flow > depreciation

106782

Quarters > 0 > cash Flow > change In Working Capital

1099643

Quarters > 0 > cash Flow > cash From Operations

-4244354

Quarters > 0 > cash Flow > capital Expenditures

4

Quarters > 0 > cash Flow > cash From Investing

-

Quarters > 0 > cash Flow > cash From Financing

1462881

Quarters > 0 > cash Flow > net Change In Cash

-2781473

Quarters > 0 > ratios > PE

-1.3516449201153482

Quarters > 0 > ratios > PB

6.942065183784602

Quarters > 0 > ratios > ROE

-211.33349416153334

Quarters > 0 > ratios > ROA

-69.78930860778873

Quarters > 0 > ratios > FCF

-4244358

Quarters > 0 > ratios > Piotroski FScore

1

Quarters > 0 > ratios > fcf Percent

-

Quarters > 0 > health Score

21

Quarters > 1 > quarter

2025-06-30

Quarters > 1 > income Statement > revenue

0

Quarters > 1 > income Statement > cost Of Revenue

146989

Quarters > 1 > income Statement > gross Profit

-146989

Quarters > 1 > income Statement > operating Expenses

4502985

Quarters > 1 > income Statement > operating Income

-4649974

Quarters > 1 > income Statement > interest Expense

138761000

Quarters > 1 > income Statement > pretax Income

-4788735

Quarters > 1 > income Statement > net Income

-4788735

Quarters > 1 > income Statement > eps

-1.0909609713256627

Quarters > 1 > income Statement > dividends Per Share

-

Quarters > 1 > income Statement > shares Outstanding

4389465

Quarters > 1 > income Statement > income Tax Expense

-

Quarters > 1 > income Statement > EBITDA

-4641745

Quarters > 1 > income Statement > operating Margin

-

Quarters > 1 > income Statement > total Other Income Expense Net

-138761

Quarters > 1 > balance Sheet > cash

8900183

Quarters > 1 > balance Sheet > short Term Investments

-

Quarters > 1 > balance Sheet > receivables

19585

Quarters > 1 > balance Sheet > inventories

-

Quarters > 1 > balance Sheet > total Current Assets

10222668

Quarters > 1 > balance Sheet > property Plant Equipment

3245540

Quarters > 1 > balance Sheet > total Assets

13468208

Quarters > 1 > balance Sheet > payables

872853

Quarters > 1 > balance Sheet > short Term Debt

5358108

Quarters > 1 > balance Sheet > long Term Debt

-

Quarters > 1 > balance Sheet > total Liabilities

7956334

Quarters > 1 > balance Sheet > equity

5511874

Quarters > 1 > cash Flow > net Income

-4788735

Quarters > 1 > cash Flow > depreciation

146989

Quarters > 1 > cash Flow > change In Working Capital

-426743

Quarters > 1 > cash Flow > cash From Operations

-4795257

Quarters > 1 > cash Flow > capital Expenditures

5923

Quarters > 1 > cash Flow > cash From Investing

-5925

Quarters > 1 > cash Flow > cash From Financing

4182399

Quarters > 1 > cash Flow > net Change In Cash

-618783

Quarters > 1 > ratios > PE

-1.0909609713256627

Quarters > 1 > ratios > PB

3.5358617776821464

Quarters > 1 > ratios > ROE

-86.8803423300315

Quarters > 1 > ratios > ROA

-35.55584380639206

Quarters > 1 > ratios > FCF

-4801180

Quarters > 1 > ratios > Piotroski FScore

0

Quarters > 1 > ratios > fcf Percent

-

Quarters > 1 > health Score

27

Quarters > 2 > quarter

2025-03-31

Quarters > 2 > income Statement > revenue

0

Quarters > 2 > income Statement > cost Of Revenue

165291

Quarters > 2 > income Statement > gross Profit

-165291

Quarters > 2 > income Statement > operating Expenses

3540744

Quarters > 2 > income Statement > operating Income

-3706035

Quarters > 2 > income Statement > interest Expense

96656000

Quarters > 2 > income Statement > pretax Income

-3802691

Quarters > 2 > income Statement > net Income

-3802691

Quarters > 2 > income Statement > eps

-1.0427207488675978

Quarters > 2 > income Statement > dividends Per Share

-

Quarters > 2 > income Statement > shares Outstanding

3646893

Quarters > 2 > income Statement > income Tax Expense

-

Quarters > 2 > income Statement > EBITDA

-3637404

Quarters > 2 > income Statement > operating Margin

-

Quarters > 2 > income Statement > total Other Income Expense Net

-96656

Quarters > 2 > balance Sheet > cash

9518966

Quarters > 2 > balance Sheet > short Term Investments

-

Quarters > 2 > balance Sheet > receivables

41573

Quarters > 2 > balance Sheet > inventories

-

Quarters > 2 > balance Sheet > total Current Assets

10504972

Quarters > 2 > balance Sheet > property Plant Equipment

1964616

Quarters > 2 > balance Sheet > total Assets

12469588

Quarters > 2 > balance Sheet > payables

855150

Quarters > 2 > balance Sheet > short Term Debt

4158080

Quarters > 2 > balance Sheet > long Term Debt

923698

Quarters > 2 > balance Sheet > total Liabilities

6538768

Quarters > 2 > balance Sheet > equity

5930820

Quarters > 2 > cash Flow > net Income

-3802691

Quarters > 2 > cash Flow > depreciation

165291

Quarters > 2 > cash Flow > change In Working Capital

-1413177

Quarters > 2 > cash Flow > cash From Operations

-4608282

Quarters > 2 > cash Flow > capital Expenditures

0

Quarters > 2 > cash Flow > cash From Investing

-

Quarters > 2 > cash Flow > cash From Financing

1915927

Quarters > 2 > cash Flow > net Change In Cash

-2692355

Quarters > 2 > ratios > PE

-1.0427207488675978

Quarters > 2 > ratios > PB

2.7301797930134453

Quarters > 2 > ratios > ROE

-64.11745761968834

Quarters > 2 > ratios > ROA

-30.49572287392334

Quarters > 2 > ratios > FCF

-4608282

Quarters > 2 > ratios > Piotroski FScore

0

Quarters > 2 > ratios > fcf Percent

-

Quarters > 2 > health Score

32

Quarters > 3 > quarter

2024-12-31

Quarters > 3 > income Statement > revenue

12982430434

Quarters > 3 > income Statement > cost Of Revenue

160302

Quarters > 3 > income Statement > gross Profit

-160302

Quarters > 3 > income Statement > operating Expenses

6048187

Quarters > 3 > income Statement > operating Income

-6208489

Quarters > 3 > income Statement > interest Expense

99000

Quarters > 3 > income Statement > pretax Income

-6131979

Quarters > 3 > income Statement > net Income

-6131979

Quarters > 3 > income Statement > eps

-1.8023008512461842

Quarters > 3 > income Statement > dividends Per Share

-

Quarters > 3 > income Statement > shares Outstanding

3402306

Quarters > 3 > income Statement > income Tax Expense

-

Quarters > 3 > income Statement > EBITDA

-5971677

Quarters > 3 > income Statement > operating Margin

-0.04782223969204132

Quarters > 3 > income Statement > total Other Income Expense Net

76510

Quarters > 3 > balance Sheet > cash

12211321

Quarters > 3 > balance Sheet > short Term Investments

-

Quarters > 3 > balance Sheet > receivables

26325

Quarters > 3 > balance Sheet > inventories

-

Quarters > 3 > balance Sheet > total Current Assets

12660803

Quarters > 3 > balance Sheet > property Plant Equipment

2203686

Quarters > 3 > balance Sheet > total Assets

14864489

Quarters > 3 > balance Sheet > payables

1270280

Quarters > 3 > balance Sheet > short Term Debt

2662200

Quarters > 3 > balance Sheet > long Term Debt

2436879

Quarters > 3 > balance Sheet > total Liabilities

7408984

Quarters > 3 > balance Sheet > equity

7455505

Quarters > 3 > cash Flow > net Income

-6131979

Quarters > 3 > cash Flow > depreciation

160302

Quarters > 3 > cash Flow > change In Working Capital

1831798

Quarters > 3 > cash Flow > cash From Operations

-4079530

Quarters > 3 > cash Flow > capital Expenditures

198462

Quarters > 3 > cash Flow > cash From Investing

-198462

Quarters > 3 > cash Flow > cash From Financing

6449164

Quarters > 3 > cash Flow > net Change In Cash

2171172

Quarters > 3 > ratios > PE

-1.8023008512461842

Quarters > 3 > ratios > PB

2.02618583717669

Quarters > 3 > ratios > ROE

-82.24766799834484

Quarters > 3 > ratios > ROA

-41.25253818008813

Quarters > 3 > ratios > FCF

-4277992

Quarters > 3 > ratios > Piotroski FScore

1

Quarters > 3 > ratios > fcf Percent

-0.0003295216578858966

Quarters > 3 > health Score

31

Valuation > metrics > PE

-1.3516449201153482

Valuation > metrics > PB

6.942065183784602

Valuation > final Score

20

Valuation > verdict

131.4% Overvalued

Profitability > metrics > ROE

-211.33349416153334

Profitability > metrics > ROA

-98.75899162015307

Profitability > final Score

15

Profitability > verdict

Weak

Risk > metrics > Debt Equity

2.028164318824442

Risk > metrics > Interest Coverage

-0.010462876358064978

Risk > final Score

18

Risk > verdict

High

Liquidity > metrics > Current Ratio

1.7358895671853256

Liquidity > metrics > Quick Ratio

1.7358895671853256

Liquidity > final Score

93

Liquidity > verdict

Great

Prev Valuations > 0

44.64138222317854

Prev Valuations > 1

80

Prev Valuations > 2

80

Prev Profitabilities > 0

15

Prev Profitabilities > 1

15

Prev Profitabilities > 2

0

Prev Risks > 0

30

Prev Risks > 1

30

Prev Risks > 2

-203

Prev Liquidities > 0

91

Prev Liquidities > 1

100

Prev Liquidities > 2

100

Updated At

2025-12-14T00:20:16.074Z